These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 30101000)
1. PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263. Munari E; Zamboni G; Lunardi G; Marconi M; Sommaggio M; Brunelli M; Martignoni G; Netto GJ; Hoque MO; Moretta F; Mingari MC; Pegoraro MC; Mariotti FR; Vacca P; Moretta L; Bogina G Oncotarget; 2018 Jul; 9(54):30465-30471. PubMed ID: 30101000 [TBL] [Abstract][Full Text] [Related]
2. Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer. Büttner R; Gosney JR; Skov BG; Adam J; Motoi N; Bloom KJ; Dietel M; Longshore JW; López-Ríos F; Penault-Llorca F; Viale G; Wotherspoon AC; Kerr KM; Tsao MS J Clin Oncol; 2017 Dec; 35(34):3867-3876. PubMed ID: 29053400 [TBL] [Abstract][Full Text] [Related]
3. Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer. Xu H; Chen X; Lin D; Zhang J; Li C; Zhang D; Zhang X Onco Targets Ther; 2019; 12():11541-11547. PubMed ID: 31920342 [TBL] [Abstract][Full Text] [Related]
4. Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA Kim HR; Cha YJ; Hong MH; Gandhi M; Levinson S; Jung I; Lee JG; Lee CY; Cho BC; Ha SJ; Shim HS Oncotarget; 2017 Oct; 8(50):87234-87243. PubMed ID: 29152077 [TBL] [Abstract][Full Text] [Related]
5. PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability. Munari E; Zamboni G; Marconi M; Sommaggio M; Brunelli M; Martignoni G; Netto GJ; Moretta F; Mingari MC; Salgarello M; Terzi A; Picece V; Pomari C; Lunardi G; Cavazza A; Rossi G; Moretta L; Bogina G Oncotarget; 2017 Oct; 8(52):90123-90131. PubMed ID: 29163815 [TBL] [Abstract][Full Text] [Related]
6. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer. McLaughlin J; Han G; Schalper KA; Carvajal-Hausdorf D; Pelekanou V; Rehman J; Velcheti V; Herbst R; LoRusso P; Rimm DL JAMA Oncol; 2016 Jan; 2(1):46-54. PubMed ID: 26562159 [TBL] [Abstract][Full Text] [Related]